,title,source,link,date
30,CHALLENGES IN TRANSPARENCY AND CONTROL HAMPER ...,IANS India Pvt Ltd,news.google.com/articles/CBMinAFodHRwczovL2lhbnMuaW4vcHItd2lyZS1kZXRhaWwvY2hhbGxlbmdlcy1pbi10cmFuc3BhcmVuY3ktYW5kLWNvbnRyb2wtaGFtcGVyLW1lcmNoYW50LWFwaS1tYXJrZXQtZ3Jvd3RoLWRlc3BpdGUtcGhhcm1hY2V1dGljYWwtaW5kdXN0cnktZXhwYW5zaW9uLTExLTExLTIwMjPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
70,Sosei Heptares Operational Highlights and Consolidated Results for ...,GlobeNewswire,news.google.com/articles/CBMiugFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMy8xMS8xMC8yNzc4MDQ4LzAvZW4vU29zZWktSGVwdGFyZXMtT3BlcmF0aW9uYWwtSGlnaGxpZ2h0cy1hbmQtQ29uc29saWRhdGVkLVJlc3VsdHMtZm9yLXRoZS1UaGlyZC1RdWFydGVyLWFuZC1GaXJzdC1OaW5lLU1vbnRocy1vZi0yMDIzLmh0bWzSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
45,Biosimilars Market Surges: Unraveling the Dynamics of Growth and ...,Kalkine Media,news.google.com/articles/CBMimwFodHRwczovL2thbGtpbmVtZWRpYS5jb20vbmV3cy93b3JsZC1uZXdzL2Jpb3NpbWlsYXJzLW1hcmtldC1zdXJnZXMtdW5yYXZlbGluZy10aGUtZHluYW1pY3Mtb2YtZ3Jvd3RoLWFuZC1pbm5vdmF0aW9uLWluLWJpb3RoZXJhcGV1dGljcy1wZml6ZXItaW5jLXNhbm9maS1zYdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
57,Focusing in on real-world evidence and its capabilities,PMLiVE,news.google.com/articles/CBMiamh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX2ludGVsbGlnZW5jZS9Gb2N1c2luZ19pbl9vbl9yZWFsLXdvcmxkX2V2aWRlbmNlX2FuZF9pdHNfY2FwYWJpbGl0aWVzXzE1MDM2NTHSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
3,Don't Expect Pfizer's Downturn to End Anytime Soon,RealMoney,news.google.com/articles/CBMiZWh0dHBzOi8vcmVhbG1vbmV5LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2Rvbi10LWV4cGVjdC1wZml6ZXItcy1kb3dudHVybi10by1lbmQtYW55dGltZS1zb29uLTE2MTM3NzU20gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
34,GLOBAL GLUCAGON-LIKE PEPTIDE 1 (GLP-1) MARKET REPORT ...,IANS India Pvt Ltd,news.google.com/articles/CBMisQFodHRwczovL2lhbnMuaW4vcHItd2lyZS1kZXRhaWwvZ2xvYmFsLWdsdWNhZ29uLWxpa2UtcGVwdGlkZS0xLWdscC0xLW1hcmtldC1yZXBvcnQtMjAyMy1rZXktcGxheWVycy1pbmNsdWRlLXBmaXplci1pbmMtYXN0cmF6ZW5lY2EtcGxjLXNhbm9maS1ub3ZvLW5vcmRpc2stYW1vbmctb3RoZXJzLTExLTExLTIwMjPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
33,"Rofecoxib Industry Growth Report | Merck, Hubei TuoChu Kang ...",Argyle Report,news.google.com/articles/CBMipgFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL25ld3Mvcm9mZWNveGliLWluZHVzdHJ5LWdyb3d0aC1yZXBvcnQtbWVyY2staHViZWktdHVvY2h1LWthbmcteXVhbi1waGFybWFjZXV0aWNhbC1jaGVtaWNhbC1jby1sdGQtY2hlbmdkdS1tZWlua2FpLWNoZW1pY2FsLWNvLWx0ZC8zNjY4MDMv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
32,(CIIE) Economic Watch: Zoom in on 6th CIIE from six perspectives,Xinhua,news.google.com/articles/CBMiSGh0dHBzOi8vZW5nbGlzaC5uZXdzLmNuLzIwMjMxMTEwLzZhOGFlNjVhYmE4NTQ0N2Q5NjgxODc2ODcxZjZlYzI0L2MuaHRtbNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
50,Effectiveness of COVID-19 vaccines against hospitalisation in Latin ...,The Lancet,news.google.com/articles/CBMiUmh0dHBzOi8vd3d3LnRoZWxhbmNldC5jb20vam91cm5hbHMvbGFuYW0vYXJ0aWNsZS9QSUlTMjY2Ny0xOTNYKDIzKTAwMjAwLTQvZnVsbHRleHTSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
67,Characteristics of real-world patients with high-risk BRAFV | CMAR,Dove Medical Press,news.google.com/articles/CBMihAFodHRwczovL3d3dy5kb3ZlcHJlc3MuY29tL2NoYXJhY3RlcmlzdGljcy1vZi1yZWFsLXdvcmxkLXBhdGllbnRzLXdpdGgtaGlnaC1yaXNrLWJyYWZ2NjAwZWstbXV0YXQtcGVlci1yZXZpZXdlZC1mdWxsdGV4dC1hcnRpY2xlLUNNQVLSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
